neurokinin a(4-10) has been researched along with phenyl acetate in 1 studies
| Studies (neurokinin a(4-10)) | Trials (neurokinin a(4-10)) | Recent Studies (post-2010) (neurokinin a(4-10)) | Studies (phenyl acetate) | Trials (phenyl acetate) | Recent Studies (post-2010) (phenyl acetate) |
|---|---|---|---|---|---|
| 34 | 0 | 0 | 41,232 | 1,558 | 8,330 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bueno, L; Carini, F; Crea, A; Criscuoli, M; D'Aranno, V; Fioramonti, J; Giuliani, S; Lecci, A; Maggi, CA; Marinoni, E; Tramontana, M | 1 |
1 other study(ies) available for neurokinin a(4-10) and phenyl acetate
| Article | Year |
|---|---|
Nepadutant pharmacokinetics and dose-effect relationships as tachykinin NK2 receptor antagonist are altered by intestinal inflammation in rodent models.
Topics: Acetates; Animals; Antidiarrheals; Biological Availability; Castor Oil; Cathartics; Colon; Dose-Response Relationship, Drug; Enteritis; Gastrointestinal Motility; In Vitro Techniques; Male; Mice; Muscle, Smooth; Neurokinin A; Peptide Fragments; Peptides, Cyclic; Rats; Rats, Sprague-Dawley; Receptors, Neurokinin-2; Urinary Bladder | 2001 |